Bactericidal Activity of TBD09 in Combination With Other Drugs in Pulmonary Tuberculosis

Clinical trial NCT07525427 · RECRUITING

Trial details

NCT number: NCT07525427
Sponsor: Gates Medical Research Institute
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Drug Susceptible Pulmonary Tuberculosis

Start date: 2026-04-14
Primary completion: 2026-11-05
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.